Patricia Clark, OD
Optometrist · Longmeadow, MANPI 1134194269
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,901 of the $6,066 with a category attached, or 64.3%. 18 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 36.5% of the total. Reporting peaked in 2023 at $2,352 and has fallen 73.5% since, to $623 in 2025. Among optometrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $52.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$2K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Oyster Point Pharma, Inc.$691
- Bausch & Lomb Americas Inc.$431
- Alcon$385
- Coopervision Inc.$240
- plus $1K from 12 others
What the payments were for
- Travel & lodging$2,12235%
- Food & beverage$3,90164%
- Education$70%
- Entertainment$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 25 | $2,216 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $1,094 |
| Oyster Point Pharma, Inc. | 21 | $691 |
| Bausch & Lomb Americas Inc. | 9 | $431 |
| Alcon | 14 | $385 |
| Coopervision Inc. | 6 | $240 |
| Novartis | 10 | $164 |
| Glaukos Corporation | 1 | $150 |
| Tarsus Pharmaceuticals, Inc. | 4 | $132 |
| Mallinckrodt Hospital Products Inc. | 1 | $113 |
| Aerie Pharmaceuticals, Inc. | 2 | $109 |
| Sun Pharmaceutical Industries Inc. | 6 | $103 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $85 |
| Amgen | 3 | $54 |
| Optos, Inc. | 1 | $36 |
| Dompe US, Inc. | 1 | $25 |
| AbbVie | 1 | $22 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$1,654
- MIEBO$240
- XIIDRA$240
- TYRVAYA$237
- Photrexa Viscous and Photrexa$150
- Precision7$124
- ACTHAR$113
- MiSight Contact Lens$106
How this compares
$6,066 in reported general payments places this provider in the 95th percentile of 1,084 optometrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 20 | $1,140 |
| Timolol Maleate | 18 | $906 |
| Latanoprost | 83 | $767 |
| Prednisolone Acetate | 14 | $529 |
| Brimonidine Tartrate | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Longmeadow
- Donald KorbBoston$373K
- Jaclyn GarlichBoston$162K
- Jessica CrookerScituate$99K
- Micaela CrowleyWestminster$88K
- Kristen BrownBoston$87K
- Timothy BossieBoston$75K
- Sabrina GaanMedfield$66K
- Blair O'ReillyDedham$43K
- John MagalhaesN Dartmouth$40K
- Anita GulmiriBrookline$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.